CDC Working Group Zostavax Recommendation Reflects FDA Labeling
This article was originally published in The Pink Sheet Daily
Executive Summary
Immunization against herpes zoster should not be broadened nor limited to persons currently excluded from the label, CDC Shingles Working Group recommends June 30.